Protein design company Arzeda announced it has raised $38 million in funding. This funding round includes new investments from Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and the venture arm of W.L. Gore & Associates (makers of Gore-Tex), which has been in a joint development agreement with Arzeda since 2022. And the previous investors also participated in the round, including the venture arm of the Continental Grain Company, Bunge Ventures, and Lewis & Clark Agrifood.
With this funding round, Arzeda will expand the production capacity of its ProSweet Enzymes and ProSweet RebM to meet strong market demand for better-tasting stevia and accelerate the commercialization of additional breakthrough products in its pipeline. To bring these products to the market, Arzeda has partnered with several global industrial leaders, including Unilever, AAK, and W.L. Gore & Associates.
Arzeda’s Intelligent Protein Design Technology is built on one of the largest proprietary datasets of high-quality protein designs linked to experimental results. It leverages the latest advances in GenAI to design and manufacture higher-performing proteins and enzymes tailored for large-scale production. And Arzeda’s proteins and enzymes enable alternatives that outperform existing products across various industries, including food, personal and home care, agriculture, chemicals, materials, pharmaceuticals, and diagnostics, in a more sustainable manner.
KEY QUOTES:
“Arzeda is at a key inflection point with its products now at commercial scale. This funding will enable Arzeda to accelerate the commercialization of its industrial biotech products, including new designer proteins and enzymes that have the ability to reduce GHG emissions. Arzeda’s Intelligent Protein Design Technology™ is transformational to many industrial verticals and they are one of the few companies that have been able to translate this promise into commercial products that solve real- world problems and create value for the customer.”
-Michael Krel, Partner at Sofinnova Partners
“We are impressed with the progress Arzeda has made in developing next-generation materials that have superior performance with a reduced environmental footprint. We are excited to further our relationship with Arzeda through this strategic investment.”
-Ed Rubin, SVP of External Ventures at W.L. Gore & Associates
“Our designed proteins and enzymes will touch every aspect of our lives in the future. I am thrilled to see Arzeda delivering on its mission. The field of protein design has experienced explosive growth in recent years but has faced challenges in translating these advances into products. Where we excel is in developing solutions that can be manufactured sustainably at scale.”
-Alexandre Zanghellini, co-founder and CEO of Arzeda
